Already a Bloomberg.com user?
Sign in with the same account.
LEVEL BIOTECHNOL said unconsolidated sales in June rose 21.64% to NT$58,625,000 from NT$48,196,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
6/2012 6/2011 Sales 58,625 48,196 YOY% 21.64%
-----------------Year-to-date----------------- Sales 229,432 257,736 YOY% -10.98% =================================================================